TY - JOUR
T1 - Enhanced blend uniformity and flowability of low drug loaded fine API blends via dry coating
T2 - The effect of mixing time and excipient size
AU - Kim, Sangah S.
AU - Castillo, Chelsea
AU - Cheikhali, Mirna
AU - Darweesh, Hadeel
AU - Kossor, Christopher
AU - Davé, Rajesh N.
N1 - Publisher Copyright:
© 2023 Elsevier B.V.
PY - 2023/3/25
Y1 - 2023/3/25
N2 - Although previous research demonstrated improved flowability, packing, fluidization, etc. of individual powders via nanoparticle dry coating, none considered its impact on very low drug loaded blends. Here, fine ibuprofen at 1, 3, and 5 wt% drug loadings (DL) was used in multi-component blends to examine the impact of the excipients size, dry coating with hydrophilic or hydrophobic silica, and mixing times on the blend uniformity, flowability and drug release rates. For uncoated active pharmaceutical ingredients (API), the blend uniformity (BU) was poor for all blends regardless of the excipient size and mixing time. In contrast, for dry coated API having low agglomerate ratio (AR), BU was dramatically improved, more so for the fine excipient blends, at lesser mixing times. For dry coated API, the fine excipient blends mixed for 30 min had enhanced flowability and lower AR; better for the lowest DL having lesser silica, likely due to mixing induced synergy of silica redistribution. For the fine excipient tablets, dry coating led to fast API release rates even with hydrophobic silica coating. Remarkably, the low AR of the dry coated API even at very low DL and amounts of silica in the blend led to the enhanced blend uniformity, flow, and API release rate.
AB - Although previous research demonstrated improved flowability, packing, fluidization, etc. of individual powders via nanoparticle dry coating, none considered its impact on very low drug loaded blends. Here, fine ibuprofen at 1, 3, and 5 wt% drug loadings (DL) was used in multi-component blends to examine the impact of the excipients size, dry coating with hydrophilic or hydrophobic silica, and mixing times on the blend uniformity, flowability and drug release rates. For uncoated active pharmaceutical ingredients (API), the blend uniformity (BU) was poor for all blends regardless of the excipient size and mixing time. In contrast, for dry coated API having low agglomerate ratio (AR), BU was dramatically improved, more so for the fine excipient blends, at lesser mixing times. For dry coated API, the fine excipient blends mixed for 30 min had enhanced flowability and lower AR; better for the lowest DL having lesser silica, likely due to mixing induced synergy of silica redistribution. For the fine excipient tablets, dry coating led to fast API release rates even with hydrophobic silica coating. Remarkably, the low AR of the dry coated API even at very low DL and amounts of silica in the blend led to the enhanced blend uniformity, flow, and API release rate.
KW - Agglomeration
KW - Blend flowability
KW - Blend uniformity
KW - Dry coating
KW - Excipient size
UR - http://www.scopus.com/inward/record.url?scp=85148367975&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85148367975&partnerID=8YFLogxK
U2 - 10.1016/j.ijpharm.2023.122722
DO - 10.1016/j.ijpharm.2023.122722
M3 - Article
C2 - 36796658
AN - SCOPUS:85148367975
SN - 0378-5173
VL - 635
JO - International Journal of Pharmaceutics
JF - International Journal of Pharmaceutics
M1 - 122722
ER -